Bampidis Vasileios, Azimonti Giovanna, Bastos Maria de Lourdes, Christensen Henrik, Dusemund Birgit, Durjava Mojca Fašmon, Kouba Maryline, López-Alonso Marta, López Puente Secundino, Marcon Francesca, Mayo Baltasar, Pechová Alena, Petkova Mariana, Ramos Fernando, Sanz Yolanda, Villa Roberto Edoardo, Woutersen Ruud, Brozzi Rosella, Galobart Jaume, Gregoretti Lucilla, Innocenti Matteo L, Sofianidis Konstantinos, Vettori Maria Vittoria, López-Gálvez Gloria
EFSA J. 2020 Dec 15;18(12):e06337. doi: 10.2903/j.efsa.2020.6337. eCollection 2020 Dec.
The Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) was asked to deliver a scientific opinion on the application for renewal of authorisation of zinc chelate of hydroxy analogue of methionine (MintrexZn) for all animal species. The FEEDAP Panel has delivered three opinions (during 2008 and 2009) on the safety and efficacy of the additive. The additive was authorised in 2010 as 'Zinc chelate of hydroxy analogue of methionine' containing 17.5-18 % zinc, 81 % (2-hydroxy-4-methylthio)butanoic acid (dl-methionine hydroxy analogue, HMTBa) and maximum 1% mineral oil. Following some modifications in the manufacturing process, the additive does not contain mineral oil and the applicant proposes the following specifications: ≥ 17 % zinc and ≥ 79 % HMTBa. The data provided indicate that the additive complies with the new specifications. No new evidence was found that would make the FEEDAP Panel reconsidering its previous conclusions on the safety for target species, consumers and environment. The applicant provided new studies on the effects of the additive on the respiratory tract and on skin and eyes. Data on the characterisation of the additive and the new studies on skin/eyes led the Panel to reconsider the safety for the user. Owing to the zinc and nickel content of MintrexZn, the handling of the additive poses a risk to users by inhalation; the additive is not a skin or eye irritant but is considered a skin sensitiser. The present application did not include a proposal for amending or supplementing the conditions of the original authorisation that would have an impact on the efficacy of the additive; therefore, there was no need for assessing the efficacy of the additive in the context of the renewal of the authorisation.
动物饲料添加剂及产品或物质专家委员会(FEEDAP)被要求就蛋氨酸羟基类似物锌螯合物(MintrexZn)在所有动物物种上的授权续展申请发表科学意见。FEEDAP专家委员会已就该添加剂的安全性和有效性发表了三份意见(在2008年至2009年期间)。该添加剂于2010年被授权为“蛋氨酸羟基类似物锌螯合物”,含锌量为17.5 - 18%,(2 - 羟基 - 4 - 甲硫基)丁酸(dl - 蛋氨酸羟基类似物,HMTBa)含量为81%,矿物油含量最高为1%。在制造工艺进行一些修改后,该添加剂不再含有矿物油,申请人提出以下规格:锌含量≥17%,HMTBa含量≥79%。所提供的数据表明该添加剂符合新规格。未发现新的证据使FEEDAP专家委员会重新考虑其先前关于目标物种、消费者和环境安全性的结论。申请人提供了关于该添加剂对呼吸道以及皮肤和眼睛影响的新研究。添加剂特性数据以及关于皮肤/眼睛的新研究使专家委员会重新考虑对使用者的安全性。由于MintrexZn的锌和镍含量,添加剂的处理对使用者存在吸入风险;该添加剂不是皮肤或眼睛刺激物,但被认为是皮肤致敏剂。本申请未包括对原授权条件进行修改或补充的提议,而这些修改或补充会对添加剂的功效产生影响;因此,在授权续展的背景下无需评估该添加剂的功效。